Q32 Bio
MA - WalthamBiotechnology
Focus: Q32 Bio is a public biotech company focused on developing biologics to restore healthy immune regulation, with a pipeline spanning oncology, dermatology, and nephrology indications. The company is publicly traded (ticker: QTTB) and based in Waltham, MA.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Q32 Bio
AI assessmentNot HiringNo open roles listed right now. Follow Q32 Bio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
ADX-914
Stable
Growth
Phase 2 asset in common inflammatory disease with large market; also in Phase 1 for safety characterization.
ADX-097
Help build intelligence for Q32 Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.